Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Sandro Graca, MSc, Lic TCM, FABORM
Sandro Graca is a member of the SAR Board of Directors; a doctoral researcher at the Faculty of Education, Health and Wellbeing, University of Wolverhampton, University of Wolverhampton, U.K., focusing on research on polycystic ovary syndrome (PCOS) and women’s health; Social Media and Outreach Editor for the European Journal of Integrative Medicine; and lead author on the Cochrane Review Group on acupuncture for assisted reproductive technology.